Clinical trials
Completed Neuromuscular Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 5 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 8 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre d'Investigation Clinique et Technologique 805 | 6 |
| Institut de Myologie, France | 6 |
| MarsiBionics | 3 |
| Guy's and St Thomas' NHS Foundation Trust | 2 |
| ResMed | 2 |
| Seoul National University Hospital | 2 |
| The Hospital for Sick Children | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Biogen | 1 |
| Breas Medical, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 62 |
| Muscular Atrophy, Spinal | 7 |
| Cerebral Palsy | 6 |
| Respiratory Insufficiency | 6 |
| Amyotrophic Lateral Sclerosis | 5 |
| Muscular Diseases | 4 |
| Muscular Dystrophy, Duchenne | 4 |
| Myotonia Congenita | 4 |
| Obesity Hypoventilation Syndrome | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.